RT Journal Article
SR Electronic
T1 RNA-sequencing improves diagnosis for neurodevelopmental disorders by identifying pathogenic non-coding variants and reinterpretation of coding variants
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.06.05.22275956
DO 10.1101/2022.06.05.22275956
A1 Jordy Dekker
A1 Rachel Schot
A1 Michiel Bongaerts
A1 Walter G. de Valk
A1 Monique M. van Veghel-Plandsoen
A1 Kathryn Monfils
A1 Hannie Douben
A1 Peter Elfferich
A1 Esmee Kasteleijn
A1 Leontine M.A. van Unen
A1 Geert Geeven
A1 Jasper J. Saris
A1 Yvette van Ierland
A1 Frans W. Verheijen
A1 Marianne L.T. van der Sterre
A1 Farah Sadeghi Niaraki
A1 Hidde H. Huidekoper
A1 Monique Williams
A1 Martina Wilke
A1 Virginie J.M. Verhoeven
A1 Marieke Joosten
A1 Anneke J.A. Kievit
A1 Ingrid M.B.H. van de Laar
A1 Lies H. Hoefsloot
A1 Marianne Hoogeveen-Westerveld
A1 Mark Nellist
A1 Grazia M.S. Mancini
A1 Tjakko J. van Ham
YR 2022
UL http://medrxiv.org/content/early/2022/06/07/2022.06.05.22275956.abstract
AB Background For neurodevelopmental disorders (NDD), a molecular diagnosis is key for predicting outcome, treatment and genetic counseling. Currently, in about half of NDD cases, routine DNA-based testing fails to establish a genetic diagnosis. Transcriptome analysis (RNA-seq) improves the diagnostic yield for some groups of diseases, but has not been applied to NDD in a routine diagnostic setting.Methods Here, we explored the diagnostic potential of RNA-seq in a cohort of 96 individuals including 67 undiagnosed NDD subjects. We created a user-friendly web-application to analyze RNA-seq data from single individuals’ cultured skin fibroblasts for genic, exonic and intronic expression outliers, based on modified OUTRIDER Z-scores. Candidate pathogenic events were complemented/matched with genomic data and, if required, confirmed with additional functional assays.Results We identified pathogenic small genomic deletions, mono-allelic expression, aberrant splicing events, deep intronic variants resulting in pseudo-exon insertion, but also synonymous and nonsynonymous variants with deleterious effects on transcription. This approach increased the diagnostic yield for NDD by 12%. Diagnostic pitfalls during transcriptome analysis include detection of splice abnormalities in putative disease genes caused by benign polymorphisms and/or absence of expression of the responsible gene in the tissue of choice. This was misleading in one case and could have led to the wrong diagnosis in the absence of appropriate phenotyping.Conclusions Nonetheless, our results demonstrate the utility of RNA-seq in molecular diagnostics and stress the importance of multidisciplinary team consultation. In particular, the approach is useful for the identification and interpretation of unexpected pathogenic changes in mRNA processing and expression in NDD.Competing Interest StatementThe authors have declared no competing interest.Funding StatementTJvH was funded by an Erasmus University Rotterdam (EUR) fellowshipAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Erasmus MC gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors (IRB protocol METC-2012-387)